tupton

We also have used Mobilab for about 5 years. It is much better than the PHH feature that comes with Meditech.

We just went LIVE with Expanse and use the Vision. Send me an email and I would be glad to help Thomas.upton@thomashealth.org

Contaminated diluent should have been discovered when running QC

If your rule syntax is causing the application to crash, you need to open a task with Meditech and have your BBK/NPR specialist take a look at your rule. It is often as simple as a space in the wrong place.

I have been using them for about a year now. The reactions are usually 1+ when incubated at RT for 5 min

Question - why are you making these cells in-house when they are readily available from a manufacturer? Cost?

Thread back from the dead.......... I just recently had an issue from the coders at my facility concerning 86885. They say I can only bill 3 of code 86885 per day. The problem is with reference lab testing. On AB ID's we get billed for 20+. If anyone has more input, I would welcome it. Thanks

No value for routine patient testing. Ditched it a couple years ago.

Rh negative units that are retyped from a blood supplier do not need to have a test for weak-D

FDA requires all products to be filtered before transfusion.

We would have also sent to the IRL. The incompatible crossmatches are a dead give-away something is formed or forming.

We use expired panel cells for rule-outs up to 4 months. We did get cited by CAP for not running controls, so we had to change our SOP to included QC of the panel used. Usually a D+ cell with Anti-D and a D-control (either saline or dilute albumin).

In this situation this would be a one-time scenario for K-neg units. However, as Galvania posted, because this patient has already formed 2 antibodies, her chances of forming another are greater. Thus, giving phenotypically similar units would be advantageous, if at all possible.

We switched to Bioscience from Immucore because of price

Blood Bank only handles Rhogam. All others by pharmacy.